When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALXN - European Patent Office thumbs down on new Alexion patent apps for Soliris
Alexion Pharmaceuticals Inc.
The European Patent Office has rejected two patent applications from Alexion Pharmaceuticals (NASDAQ:ALXN) for pharmaceutical compositions and composition of matter of top seller Soliris (eculizumab), potentially opening the European market to biosimilars as early as 2023 according to Leerink's Geoffrey Porges.
More news on: Alexion Pharmaceuticals, Inc., Healthcare stocks news,